• 508 Citations
  • 13 h-Index
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

Dr King has an interest in genetic variability and disease/treatment outcomes and is a member of the Australian Centre for Precision Health. Dr King has worked in multiple sclerosis and rheumatoid arthritis genetics/pharmacogenomics, and has an interest in mendelian randomisation.

Education/Academic qualification

PhD, School of Pharmacy, Queen's University Belfast, Belfast, UK.

Masters, School of Pharmacy, Queen's University Belfast, Belfast, UK.

Keywords

  • Genetics
  • Pharmacogenomics
  • Mendelian randomisation

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

1 Citation (Scopus)

Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritis

Hopkins, A. M., Wiese, M. D., King, C. & Proudman, S. M., 1 Apr 2017, In : Clinical Rheumatology. 36, 4, p. 791-798 8 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study

Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M., Jokubaitis, V. G., McKay, F. C., Gatt, P. N., Fabis-Pedrini, M. J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A. G., Slee, M., Taylor, B. V. & 5 others, Vandenbroeck, K., Comabella, M., Boneschi, F. M., King, C. & The Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), 1 Jul 2017, In : Pharmacogenomics Journal. 17, 4, p. 312-318 7 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis

Hopkins, A. M., Wiese, M. D., Proudman, S. M., King, C., Upton, R. N. & Foster, D. J. R., 1 Jan 2016, In : British Journal of Clinical Pharmacology. 81, 1, p. 113-123 11 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)